Long-term outcome of a phase II trial using immunomodulatory in situ gene therapy in combination with intensity-modulated radiotherapy with or without hormonal therapy in the treatment of prostate cancer

Bin Teh, Hiromichi Ishiyama, Wei Yuan Mai, Timothy C. Thompson, E. Brian Butler

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Long-term outcome of a phase II trial using immunomodulatory in situ gene therapy in combination with intensity-modulated radiotherapy with or without hormonal therapy in the treatment of prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences